| Sreenivasa R. Nakka, Inc | |
|
949 Calhoun Pl Ste A Hemet CA 92543-4403 | |
| (951) 929-1177 | |
| (951) 765-9111 |
| Full Name | Sreenivasa R. Nakka, Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 949 Calhoun Pl, Hemet, California |
| Authorized Official Name and Position | Sreenivasa R Nakka (PRESIDENT) |
| Authorized Official Contact | 9519291177 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sreenivasa R. Nakka, Inc 949 Calhoun Pl Ste A Hemet CA 92543-4403 Ph: (951) 929-1177 | Sreenivasa R. Nakka, Inc 949 Calhoun Pl Ste A Hemet CA 92543-4403 Ph: (951) 929-1177 |
| NPI Number | 1003184979 |
|---|---|
| Provider Enumeration Date | 12/07/2011 |
| Last Update Date | 12/07/2011 |
| Medicare PECOS PAC ID | 6709052269 |
|---|---|
| Medicare Enrollment ID | O20120104000640 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for the use of menadione to prevent and treat skin rash in patients taking biologic and small molecule epidermal growth factor receptor inhibitors, such as Erbitux® and Tarceva®, for anti-cancer therapy.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder arthroplasty with one implant system.
News reports indicate that the American College of Physicians, which is focusing this message on treatment choices for diabetes and back pain, sees this idea as a way for patients to get the most out of their their health care dollars.
People with diabetes have about double the risk of premature death as people of the same age without diabetes.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003184979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Sreenivasa R Nakka |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1184666547 PECOS PAC ID: 7517018062 Enrollment ID: I20090624000214 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for the use of menadione to prevent and treat skin rash in patients taking biologic and small molecule epidermal growth factor receptor inhibitors, such as Erbitux® and Tarceva®, for anti-cancer therapy.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder arthroplasty with one implant system.
News reports indicate that the American College of Physicians, which is focusing this message on treatment choices for diabetes and back pain, sees this idea as a way for patients to get the most out of their their health care dollars.
People with diabetes have about double the risk of premature death as people of the same age without diabetes.
› Verified 7 days ago
| Provider Name | Anas Kawayeh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1821296591 PECOS PAC ID: 9335272590 Enrollment ID: I20100809000840 |
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for the use of menadione to prevent and treat skin rash in patients taking biologic and small molecule epidermal growth factor receptor inhibitors, such as Erbitux® and Tarceva®, for anti-cancer therapy.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder arthroplasty with one implant system.
News reports indicate that the American College of Physicians, which is focusing this message on treatment choices for diabetes and back pain, sees this idea as a way for patients to get the most out of their their health care dollars.
People with diabetes have about double the risk of premature death as people of the same age without diabetes.
› Verified 7 days ago
News Archive
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for the use of menadione to prevent and treat skin rash in patients taking biologic and small molecule epidermal growth factor receptor inhibitors, such as Erbitux® and Tarceva®, for anti-cancer therapy.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder arthroplasty with one implant system.
News reports indicate that the American College of Physicians, which is focusing this message on treatment choices for diabetes and back pain, sees this idea as a way for patients to get the most out of their their health care dollars.
People with diabetes have about double the risk of premature death as people of the same age without diabetes.
› Verified 7 days ago
Mdcare Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1278 E Latham Ave, Hemet, CA 92543 Phone: 951-537-9868 | |
Guilherme R Carvalho M.d. Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 118 N Santa Fe St, Ste A, Hemet, CA 92543 Phone: 951-652-6891 | |
David Perz, D.o. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2591 W Florida Ave, Hemet, CA 92545 Phone: 951-766-4329 Fax: 951-766-8056 | |
Tri-state Community Healthcare Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 540 N San Jacinto St Ste P, Hemet, CA 92543 Phone: 951-929-4000 | |
Sj Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 422 N San Jacinto St, Hemet, CA 92543 Phone: 951-566-6585 Fax: 888-696-2590 | |
Innercare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1023 E Florida Ave, Hemet, CA 92543 Phone: 951-599-8403 Fax: 951-766-0930 |